Power Law company profile

Insitro

Biotech & Life Sciences · San Francisco, United States · Founded 2018 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Insitro is revolutionizing pharmaceutical R&D by leveraging machine learning for drug discovery

Investors

16 investors on Insitro's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 8 investors entered at this stage

Foresite Capital

Alexandria Venture Investments

ARCH Venture Partners

Bezos Expeditions

Series B+ 8 investors entered at this stage

HOF Capital

Global footprint

Where Insitro has talent and traffic

AI talent share

13.5% of workforce is AI talent
(34 of 251 staff)

Core AI259.96%

Other AI93.59%

Non-AI workforce21786.45%

Workforce by country

8 countries with
team presence

🇺🇸 United States95.9%

🇵🇱 Poland1.3%

🇨🇦 Canada0.7%

🇮🇱 Israel0.4%

🏳️ Democratic Republic of the Congo0.4%

Top 5 of 8 shown

Web traffic by country

17K monthly visits
across markets

🇺🇸 United States78.2%

🇮🇳 India9.4%

🇨🇦 Canada5.9%

🇩🇪 Germany4.1%

🇮🇱 Israel1.8%

Top 5 markets shown

Patent intelligence

$13M patent portfolio · 38 active families

Estimated portfolio value

$13M

0.53% of valuation · 73.1× smaller than top peer Globus Medical ($930M)

38 active patent families

Where Insitro innovates OligonucleotideMolecular biologyNucleotideLibraryOrganic chemistry

Where Insitro concentrates vs peers

Each axis is a top-10 topic across Insitro and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Sentiment on X

What X is saying about Insitro

An AI-synthesized read of the highest-engagement posts about Insitro on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Insitro on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles